Breaking down the Mammography Medical Audit: Definitions and Applications in the Clinical Practice

Purpose: Create an overview of the breast imaging audit as outlined by the ACR, depict current national benchmarks, review recent literature for optimal performance of screening and diagnostic mammography, and provide examples of how to apply this information in breast imaging facilities to optimize mammographic interpretation, with the goal of improving patient care by early detection and timely treatment of breast cancer.

Methods/Materials: Review the Basic Clinically Relevant Audit
Summary of Definitions
Goals of Screening Mammography
Acceptable Ranges of Screening and Diagnostic Mammography Performance
Practice implementation examples

Results: The 1992 Mammography Quality Standards Act (MQSA), mandated by the FDA, ensures nationwide quality control in mammography facilities. It mandates personnel training, rigorous quality control, and record-keeping, with continuous outcome monitoring for accurate interpretations. The ACR guides data recording for clinically relevant analysis, comparing it with national benchmarks to evaluate breast cancer screening goals. The mammography medical audit analyzes three key data sets: positive screening/diagnostic mammograms, biopsy results for recommended tissue sampling, and false negatives within a year. This framework proposes algorithms for ongoing practice improvement, optimizing interpretation, and enhancing patient outcomes in radiology practices.

Conclusions: By aligning with MQSA requirements, following ACR guidelines, and leveraging the latest advancements in the field, healthcare professionals can enhance the accuracy and effectiveness of mammographic interpretations. As we continue to advance in our understanding and technologies, the commitment to maintaining and exceeding these standards remains essential for ensuring the best possible outcomes for individuals undergoing breast cancer screening.